Mark Duncan, MD

Personal Statement

I have pursued a career at the intersection of mental health and primary care, training in both family medicine and addiction psychiatry.  I currently practice in various integrated care settings as a consulting psychiatrist and in the outpatient adult psychiatry clinic.  I am the co-medical director for the University of Washington Psychiatry and Addiction Case Conference (UW PACC), a weekly online learning collaborative to help community providers across the state improve their psychiatric and addiction clinical skills.  My area of interest is focused on improving addiction and psychiatric treatment to primary care settings.  I also spend a significant amount of time training both family medicine and psychiatry trainees and fellows on integrated treatments for substance use disorders.

Education

Rush University Medical education, 2006
West Suburban Medical Center Residency, Family Medicine
University of Washington - School of Medicine Residency, Psychiatry
University of Washington - School of Medicine Fellowship, Addiction Psychiatry

Department Affiliations

Recent Publications

Safer-use strategies in the context of harm-reduction treatment for people experiencing homelessness and alcohol use disorder.
(2024 Jun 20)
Int J Drug Policy 129(): 104448
Alawadhi YT, Shinagawa E, Taylor EM, Jackson C, Fragasso A, Howard M, Fan L, Kolpikova E, Karra S, Frohe T, Clifasefi SL, Duncan MH, Collins SE

Project ECHO in Psychiatric Workforce Development: the Example of a Perinatal Mental Health ECHO.
(2024 Jun)
Acad Psychiatry 48(3): 249-253
Ramaraj AB, Franz NA, Bhat A, Adachi J, Quiray JA, Bespalova N, Duncan MH, Cowley DS

Does Screening for Opioid Use Disorder in Primary Care Increase the Percentage of Patients With a New Diagnosis?
(2023 Oct)
Ann Intern Med 176(10): 1431-1433
Fortney JC, Ratzliff AD, Blanchard BE, Johnson M, Ferro L, Austin EJ, Williams EC, Duncan MH, Merrill JO, Thomas J, Kitay B, Schoenbaum M, Heagerty PJ, Saxon AJ

Feasibility, Engagement, and Usability of a Remote, Smartphone-Based Contingency Management Program as a Treatment Add-On for Patients Who Use Methamphetamine: Single-Arm Pilot Study.
(2023 Jul 6)
JMIR Form Res 7(): e47516
Hallgren KA, Duncan MH, Iles-Shih MD, Cohn EB, McCabe CJ, Chang YM, Saxon AJ

Extended-release Naltrexone Is Not Linked to Hepatotoxicity in Adults Experiencing Homelessness and Alcohol Use Disorder.
(2023 May-Jun 01)
J Addict Med 17(3): 363-366
Vutien P, Kim NJ, Merrill JO, Duncan MH, Ioannou GN, Collins SE

Show complete publication list »
Edit Profile